Theme
Biotech '25: Oncology & Immunotherapy☆
ACLX-27.47%8.3%
AVBP-20.92%8.3%
CGEM+119.29%8.3%
CRSP-32.67%8.3%
JANX-28.43%8.3%
NRIX+104.51%8.3%
NUVB+32.00%8.3%
NUVL0.00%8.3%
PTGX+108.70%8.3%
RIGL+71.55%8.3%
RVMD+295.09%8.3%
ZYME+49.29%8.3%
As of Oct 9, 2026, 4:27 AM ET
Biotech '25: Oncology & Immunotherapy Constituents
Arcellx, Inc.ACLX | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | -1.67% | 0.00% | -4.64% | -27.47% | -20.70% | 281.61% | $3.75B |
ArriVent BioPharma, Inc.AVBP | 8.3% | -1.07% | -42.97% | -43.91% | -42.24% | -16.95% | -27.25% | -7.17% | -20.92% | -38.99% | -7.17% | $778.3M |
CRISPR Therapeutics AGCRSP | 8.3% | -3.65% | -6.75% | -5.63% | -9.02% | -3.81% | -16.13% | 47.53% | -32.67% | 11.59% | -48.86% | $4.86B |
Cullinan Therapeutics, Inc.CGEM | 8.3% | -1.09% | 3.41% | -27.45% | 6.40% | 49.37% | -0.26% | 97.70% | 119.29% | -4.03% | -35.10% | $950.1M |
Janux Therapeutics, Inc.JANX | 8.3% | 3.24% | 11.58% | -4.29% | 9.08% | 34.06% | 35.93% | -34.51% | -28.43% | -58.82% | -13.19% | $1.13B |
Nurix Therapeutics, Inc.NRIX | 8.3% | -2.29% | -6.17% | -15.42% | -4.84% | 17.08% | 39.07% | 95.17% | 104.51% | 0.95% | -19.41% | $2.30B |
Nuvalent, Inc.NUVL | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 21.01% | $1.62B |
Nuvation Bio Inc.NUVB | 8.3% | 1.85% | -11.61% | -24.08% | -10.97% | -44.75% | -16.24% | 176.54% | 32.00% | 121.97% | -45.66% | $1.72B |
Protagonist Therapeutics, Inc.PTGX | 8.3% | -0.72% | -1.78% | -3.57% | 0.52% | 60.19% | 51.94% | 190.27% | 108.70% | 218.27% | 667.05% | $9.00B |
Revolution Medicines, Inc.RVMD | 8.3% | -6.35% | -6.75% | -9.42% | -8.63% | 136.18% | 84.40% | 443.70% | 295.09% | 277.98% | 577.18% | $39.99B |
Rigel Pharmaceuticals, Inc.RIGL | 8.3% | 1.52% | -1.30% | 3.18% | 3.73% | 13.75% | 40.24% | 167.55% | 71.55% | 210.32% | 41.63% | $901.4M |
Zymeworks Inc.ZYME | 8.3% | -4.79% | -6.86% | -6.96% | -2.70% | -4.06% | 8.46% | 111.91% | 49.29% | 101.60% | 2.72% | $1.86B |
| Theme return | — | -1.11% | -5.77% | -11.26% | -3.78% | 23.42% | 21.15% | 114.80% | 60.74% | 76.96% | 162.99% | — |
| Average | 8.3% | -1.11% | -5.77% | -11.46% | -4.89% | 19.95% | 16.68% | 107.00% | 55.91% | 68.34% | 118.48% | $5.74B |
| Median | 8.3% | -0.89% | -3.97% | -6.29% | -1.35% | 6.88% | 4.23% | 96.44% | 40.64% | 6.27% | -2.22% | $1.79B |
| Std Dev | 0.0% | 2.68% | 12.61% | 13.33% | 12.72% | 44.53% | 31.96% | 125.69% | 90.45% | 109.49% | 241.08% | $10.57B |
| Min | 8.3% | -6.35% | -42.97% | -43.91% | -42.24% | -44.75% | -27.25% | -34.51% | -32.67% | -58.82% | -48.86% | $778.3M |
| Max | 8.3% | 3.24% | 11.58% | 3.18% | 9.08% | 136.18% | 84.40% | 443.70% | 295.09% | 277.98% | 667.05% | $39.99B |
| % Positive Tickers | 25.00% | 16.67% | 8.33% | 33.33% | 50.00% | 50.00% | 66.67% | 58.33% | 58.33% | 50.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort